Profile
Philippe Hénon is the founder of CellProthera SAS and Institut de Recherche en Hématologie et Transplantation.
He held the title of Chairman & Chief Scientific Officer at CellProthera SAS and Director at Institut de Recherche en Hématologie et Transplantation.
CellProthera SAS was founded in 2008 and Institut de Recherche en Hématologie et Transplantation was founded in 1987.
Dr. Hénon earned a doctorate degree from Université Paris 1 Panthéon-Sorbonne in 1968.
Former positions of Philippe Hénon
| Companies | Position | End |
|---|---|---|
CellProthera SAS
 CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France. | Founder | - |
| Institut de Recherche en Hématologie et Transplantation | Founder | - |
Training of Philippe Hénon
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
CellProthera SAS
CellProthera SAS Medical/Nursing ServicesHealth Services CellProthera SAS operates as a holding company with interests in medical studies on heart diseases. The firm focuses on the development of a stem cell therapy for the regeneration of myocardial tissue allowing the prevention of chronic heart failure following acute myocardial infarct by injecting a cell graft containing antilogous adult stem cells sampled directly from the patient. The company was founded by Philippe H?non in April 2008 and is headquartered in Mulhouse, France. | Health Services |
| Institut de Recherche en Hématologie et Transplantation |
- Stock Market
- Insiders
- Philippe Hénon
